Background: It is unknown whether renal pathology lesions in immunoglobulin A nephropathy (IgAN) correlate with renal outcomes over decades of follow-up. Methods: In 1130 patients of the original Validation Study of the Oxford Classification for IgA Nephropathy (VALIGA) cohort, we studied the relationship between the MEST score (mesangial hypercellularity, M; endocapillary hypercellularity, E; segmental glomerulosclerosis, S; tubular atrophy/interstitial fibrosis, T), crescents (C) and other histological lesions with both a combined renal endpoint [50% estimated glomerular filtration rate (eGFR) loss or kidney failure] and the rate of eGFR decline over a follow-up period extending to 35 years [median 7 years (interquartile range 4.1-10.8)]. Results: In this extended analysis, M1, S1 and T1-T2 lesions as well as the whole MEST score were independently related with the combined endpoint (P < 0.01), and there was no effect modification by age for these associations, suggesting that they may be valid in children and in adults as well. Only T lesions were associated with the rate of eGFR loss in the whole cohort, whereas C showed this association only in patients not treated with immunosuppression. In separate prognostic analyses, the whole set of pathology lesions provided a gain in discrimination power over the clinical variables alone, which was similar at 5 years (+2.0%) and for the whole follow-up (+1.8%). A similar benefit was observed for risk reclassification analyses (+2.7% and +2.4%). Conclusion: Long-term follow-up analyses of the VALIGA cohort showed that the independent relationship between kidney biopsy findings and the risk of progression towards kidney failure in IgAN remains unchanged across all age groups and decades after the renal biopsy.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update / Coppo, R.; D'Arrigo, G.; Tripepi, G.; Russo, M. L.; Roberts, I. S. D.; Bellur, S.; Cattran, D.; Cook, T. H.; Feehally, J.; Tesar, V.; Maixnerova, D.; Peruzzi, L.; Amore, A.; Lundberg, S.; Di Palma, A. M.; Gesualdo, L.; Emma, F.; Rollino, C.; Praga, M.; Biancone, L.; Pani, A.; Feriozzi, S.; Polci, R.; Barratt, J.; Del Vecchio, L.; Locatelli, F.; Pierucci, A.; Caliskan, Y.; Perkowska-Ptasinska, A.; Durlik, M.; Moggia, E.; Ballarin, J. C.; Wetzels, J. F. M.; Goumenos, D.; Papasotiriou, M.; Galesic, K.; Toric, L.; Papagianni, A.; Stangou, M.; Benozzi, L.; Cusinato, S.; Berg, U.; Topaloglu, R.; Maggio, M.; Ots-Rosenberg, M.; D'Amico, M.; Geddes, C.; Balafa, O.; Quaglia, M.; Cravero, R.; Lino Cirami, C.; Fellstrom, B.; Floege, J.; Egido, J.; Mallamaci, F.; Zoccali, C.. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 35:6(2018), pp. 1002-1009. [10.1093/ndt/gfy302]

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

Pierucci A.;
2018

Abstract

Background: It is unknown whether renal pathology lesions in immunoglobulin A nephropathy (IgAN) correlate with renal outcomes over decades of follow-up. Methods: In 1130 patients of the original Validation Study of the Oxford Classification for IgA Nephropathy (VALIGA) cohort, we studied the relationship between the MEST score (mesangial hypercellularity, M; endocapillary hypercellularity, E; segmental glomerulosclerosis, S; tubular atrophy/interstitial fibrosis, T), crescents (C) and other histological lesions with both a combined renal endpoint [50% estimated glomerular filtration rate (eGFR) loss or kidney failure] and the rate of eGFR decline over a follow-up period extending to 35 years [median 7 years (interquartile range 4.1-10.8)]. Results: In this extended analysis, M1, S1 and T1-T2 lesions as well as the whole MEST score were independently related with the combined endpoint (P < 0.01), and there was no effect modification by age for these associations, suggesting that they may be valid in children and in adults as well. Only T lesions were associated with the rate of eGFR loss in the whole cohort, whereas C showed this association only in patients not treated with immunosuppression. In separate prognostic analyses, the whole set of pathology lesions provided a gain in discrimination power over the clinical variables alone, which was similar at 5 years (+2.0%) and for the whole follow-up (+1.8%). A similar benefit was observed for risk reclassification analyses (+2.7% and +2.4%). Conclusion: Long-term follow-up analyses of the VALIGA cohort showed that the independent relationship between kidney biopsy findings and the risk of progression towards kidney failure in IgAN remains unchanged across all age groups and decades after the renal biopsy.
2018
IgA nephropathy; progression; renal biopsy; risk factors; Adolescent; Adult; Child; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Kidney; Male; Prognosis
01 Pubblicazione su rivista::01a Articolo in rivista
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update / Coppo, R.; D'Arrigo, G.; Tripepi, G.; Russo, M. L.; Roberts, I. S. D.; Bellur, S.; Cattran, D.; Cook, T. H.; Feehally, J.; Tesar, V.; Maixnerova, D.; Peruzzi, L.; Amore, A.; Lundberg, S.; Di Palma, A. M.; Gesualdo, L.; Emma, F.; Rollino, C.; Praga, M.; Biancone, L.; Pani, A.; Feriozzi, S.; Polci, R.; Barratt, J.; Del Vecchio, L.; Locatelli, F.; Pierucci, A.; Caliskan, Y.; Perkowska-Ptasinska, A.; Durlik, M.; Moggia, E.; Ballarin, J. C.; Wetzels, J. F. M.; Goumenos, D.; Papasotiriou, M.; Galesic, K.; Toric, L.; Papagianni, A.; Stangou, M.; Benozzi, L.; Cusinato, S.; Berg, U.; Topaloglu, R.; Maggio, M.; Ots-Rosenberg, M.; D'Amico, M.; Geddes, C.; Balafa, O.; Quaglia, M.; Cravero, R.; Lino Cirami, C.; Fellstrom, B.; Floege, J.; Egido, J.; Mallamaci, F.; Zoccali, C.. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 35:6(2018), pp. 1002-1009. [10.1093/ndt/gfy302]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1511754
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 33
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 50
social impact